Active ingredientMeldonium dihydrateCat. No. P-M038-001CAS 86426-17-7Family · Pharmaceutical analytical standards
Meldonium
An anti-ischaemic medicine developed in the 1970s by Ivars Kalviņš at the Latvian Institute of Organic Synthesis; it is used mainly in Eastern Europe for angina and heart failure. This family brings together the active ingredient, pharmacopoeial impurities, labelled standards and other impurities.
Did you know?It is almost a twin of gamma-butyrobetaine, the precursor of carnitine: one nitrogen atom in place of a carbon is enough to block the enzyme that makes carnitine.
Go to the active ingredient →Active ingredientMeldonium dihydrateCat. No. P-M038-001CAS 86426-17-7
Pharmacopoeial impurityMeldonium EP Impurity ACat. No. P-M038-002CAS 2840-24-6
Pharmacopoeial impurityMeldonium EP Impurity BCat. No. P-M038-003CAS 34810-18-9
Pharmacopoeial impurityMeldonium EP Impurity CCat. No. P-M038-004CAS 106966-25-0
Pharmacopoeial impurityMeldonium EP Impurity DCat. No. P-M038-005CAS 76144-84-8
Pharmacopoeial impurityMeldonium EP Impurity ECat. No. P-M038-006CAS 1093122-25-8
Pharmacopoeial impurityMeldonium EP Impurity FCat. No. P-M038-007
Isotopically labelledMildronate-d3Cat. No. P-M038-008
Isotopically labelledMildronate-d3 HClCat. No. P-M038-009
Active ingredientMeldoniumCat. No. P-M038-010CAS 76144-81-5
ImpurityMildronate Impurity ACat. No. P-M038-011
ImpurityMildronate Impurity BCat. No. P-M038-012No product matches your search.
EDQM standards 7
The official European Pharmacopoeia standards for this family.
Reference substanceMeldonium dihydrate CRSEDQM code Y0001670Family MeldoniumImpurityMeldonium impurity A CRSEDQM code Y0001671Family MeldoniumImpurityMeldonium impurity B CRSEDQM code Y0001672Family MeldoniumImpurityMeldonium impurity C CRSEDQM code Y0001673Family MeldoniumImpurityMeldonium impurity D CRSEDQM code Y0001674Family MeldoniumImpurityMeldonium impurity E CRSEDQM code Y0001675Family MeldoniumImpurityMeldonium impurity F CRSEDQM code Y0001676Family MeldoniumNeed a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.